from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1582c/-

LFCtreatmentdescriptionclass of inhibitor

-0.183

Amikacinug/mL Amikacintranslation

0.168

Cap5-10ug/mL Capreomycintranslation

0.393

Rox10-50 ug/mL Roxithromycintranslation

0.205

SM2-5 ug/mL Streptomycintranslation

1.967

Tet5-10 ug/mL Tetracyclinetranslation

0.031

Rif0.2-5ug/mL Rifampicintranscription

0.241

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.631

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.257

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.328

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.937

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.032

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.040

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.313

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.291

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.512

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-0.502

NaN30.2-2 mM Sodium aziderespiration

-1.207

Nigericin50 uM Nigericinrespiration

-0.011

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

1.423

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.739

menadione6-10 ug/mL Menadionerespiration

0.209

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.170

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.397

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.059

NRP_1Non-replicating persistence stage 1dosRassociated

0.561

Amp0.2mg/mL AmpicillincellWall

-0.017

Cephalexin20-100 ug/mL CephalexincellWall

0.827

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.382

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.248

EMB10-20 ug/mL EthambutolcellWall

0.238

Eta12-40 ug/mL EthionamidecellWall

0.116

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.483

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.415

BZA0.12 mg/mL BenzamidearomaticAmides

-0.311

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.149

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.029

H2O24 mM hydrogen peroxideDNAdamaging

0.076

Levo10 ug/mL LevofloxacinDNAdamaging

-0.047

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.097

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.374

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.210

Antimycin12.5-50 ug/mL Antimycin A?

-0.902

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.315

PA_110-50 ug/mL Antitubercular compound PA-1?

1.007

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.071

PA8240.2-2 ug/mL PA-824?

-0.398

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.694

Verapamil50 uM Verapamil?

-1.516

mercaptoethanol2 mM 2-Mercaptoethanol?

0.599

methoxatin10-20 ug/mL Methoxatin?